These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36854528)

  • 1. Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells
    Park JH; Lee JS; Shin JK; Sharma S; Kim HS; Yoon S
    Anticancer Res; 2023 Mar; 43(3):1103-1112. PubMed ID: 36854528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance.
    Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
    Anticancer Res; 2022 May; 42(5):2433-2442. PubMed ID: 35489775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells.
    Shin JK; Kim HS; Yoon S
    Anticancer Res; 2024 Mar; 44(3):1051-1062. PubMed ID: 38423668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
    Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
    Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S
    Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.
    Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Kim JY; Park YJ; Lee BM; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells.
    Jiang C; Zheng T; Park JH; Lee JS; Oh Y; Kundu A; Kim HS; Yoon S
    Anticancer Res; 2021 Dec; 41(12):6179-6190. PubMed ID: 34848472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.
    Kim JY; Kim HS; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3785-3793. PubMed ID: 31262905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.
    Lee JS; Oh Y; Park JH; Kyung SY; Kim HS; Yoon S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Kim JY; Park Y; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Oct; 38(10):5685-5692. PubMed ID: 30275188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Kim JY; Kim KS; Kim IS; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3767-3775. PubMed ID: 31262903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Kim JY; Son JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Sep; 38(9):5149-5157. PubMed ID: 30194162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
    Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
    Lee JS; Oh Y; Kim HS; Yoon S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition.
    Choi AR; Jee Jo M; Jung MJ; Sik Kim H; Yoon S
    Eur J Pharmacol; 2015 Oct; 764():63-69. PubMed ID: 26134503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.
    Kim JY; Tae IH; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Sep; 38(9):5101-5108. PubMed ID: 30194155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Park Y; Son JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2017 Aug; 37(8):4139-4146. PubMed ID: 28739698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
    Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
    Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis
    Kim KS; Jiang C; Kim JY; Park JH; Kim HR; Lee SH; Kim HS; Yoon S
    Front Oncol; 2020; 10():696. PubMed ID: 32528877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.